Sumitomo Mitsui Trust Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-907,930
| Closed | -$9.16M | – | 1163 |
|
|
2022
Q4 | $9.16M | Sell |
907,930
-380,928
| -30% | -$3.84M | 0.01% | 791 |
|
|
2022
Q3 | $28.9M | Buy |
1,288,858
+18,293
| +1% | +$410K | 0.02% | 634 |
|
|
2022
Q2 | $31.5M | Buy |
1,270,565
+7,699
| +0.6% | +$191K | 0.02% | 636 |
|
|
2022
Q1 | $49M | Buy |
1,262,866
+20,023
| +2% | +$776K | 0.03% | 543 |
|
|
2021
Q4 | $72.7M | Sell |
1,242,843
-3,727
| -0.3% | -$218K | 0.04% | 434 |
|
|
2021
Q3 | $73.9M | Buy |
1,246,570
+214,490
| +21% | +$12.7M | 0.05% | 427 |
|
|
2021
Q2 | $89.6M | Buy |
1,032,080
+470,485
| +84% | +$40.8M | 0.05% | 381 |
|
|
2021
Q1 | $46.3M | Buy |
561,595
+23,931
| +4% | +$1.97M | 0.03% | 564 |
|
|
2020
Q4 | $48.9M | Buy |
537,664
+55,238
| +11% | +$5.02M | 0.03% | 543 |
|
|
2020
Q3 | $19.3M | Sell |
482,426
-49,778
| -9% | -$1.99M | 0.01% | 695 |
|
|
2020
Q2 | $18.3M | Sell |
532,204
-393,805
| -43% | -$13.5M | 0.01% | 691 |
|
|
2020
Q1 | $20.6M | Buy |
926,009
+106,199
| +13% | +$2.36M | 0.02% | 626 |
|
|
2019
Q4 | $16M | Sell |
819,810
-20,620
| -2% | -$404K | 0.01% | 698 |
|
|
2019
Q3 | $13.1M | Buy |
840,430
+331,589
| +65% | +$5.15M | 0.01% | 700 |
|
|
2019
Q2 | $10.3M | Buy |
+508,841
| New | +$10.3M | 0.01% | 718 |
|